An Evening With Professor Wayne McIlwraith

Hear From A Global Voice in Joint Health and OA

Professor Wayne McIlwraith is widely recognised as one of the world’s foremost authorities in Equine joint health and osteoarthritis. With over four decades of groundbreaking research and clinical practice at Colorado State University, Professor McIlwraith has transformed how we understand and treat joint disease across species.

Appointed Officer of the New Zealand Order of Merit (ONZM) in the 2025 New Year Honours for his distinguished contributions to veterinary medicine and the equine industry, and recipient of the American Association of Equine Practitioners’ Research Award for his life-long contributions to equine research in orthopaedics, joint disease and biologic therapies, he is a University Distinguished Professor at Colorado State University, founder of the Orthopaedic Research Center, and namesake of the C. Wayne McIlwraith Translational Medicine Institute. His work has transformed orthopaedics across both veterinary and human medicine.

His contributions to the field include:

• Pioneering arthroscopic surgery techniques that revolutionised orthopaedics
• Founding the CSU Orthopaedic Research Center, now one of the world’s leading research facilities
• Having an entire institute named in his honour – the C. Wayne McIlwraith Translational Medicine Institute
• Bridging veterinary and human medicine through translational research that benefits both animals and people
• Receiving lifetime achievement awards from the American Veterinary Medical Association, American College of Veterinary Surgeons, and being appointed Officer of the New Zealand Order of Merit
• Authoring over 400 publications and five textbooks on joint health and orthopaedics
• Training clinicians worldwide in advanced surgical and regenerative therapies

WHAT YOU’LL LEARN:

Professor McIlwraith will present on the latest research data from Colorado State University on 2.5% injectable polyacrylamide hydrogel (2.5% iPAAG).

✓ Mechanism of action – How 2.5% iPAAG augments the joint capsule and modifies OA progression

✓ Real-world applications and treatment protocols for your practice

✓ Comprehensive safety data and long-term efficacy results from multiple clinical trials

✓ The future of regenerative joint therapies and where the research is heading

JOINING WAYNE:

Dr Leigh de Clifford will also be presenting the data of his recent study: Retrospective analysis of the long-term use of 2.5% injectable polyacrylamide hydrogel (2.5% iPAAG) in a Thoroughbred racehorse practice: Safety on 701 horses, Efficacy on 205 horses. This research, showcased at Bain Fallon 2025 and AAEP 2025, brings international-level insights right to New Zealand.

Whether you’re managing performance animals, treating chronic OA cases, or exploring innovative therapeutic options, this is your opportunity to learn directly from the expert who has shaped modern orthopaedics.

EVENT DETAILS:

DATE: Monday, 9 February 2026

TIME:
Arrive from 6:30 PM
Talk begins at 7:00 PM

LOCATION:
Velo 2 Room
Grassroots Trust Velodrome
Cambridge

REFRESHMENTS:
Drinks and nibbles provided throughout the evening

VETERINARIANS ONLY

This is an exclusive professional development evening for registered veterinarians. Spaces are limited to ensure an intimate and engaging experience.

This event is brought to you by Arthramid® in association with the Waikato Branch of NZVA

REGISTER HERE

Please RSVP by Thursday 5 Feb for catering purposes